Clinical and Technical Validation of OncoIndx
artificial intelligence
cancer genomics
comprehensive genomic profiling (CGP)
next-generation sequencing (NGS)
targeted gene sequencing
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
08 Oct 2024
08 Oct 2024
Historique:
received:
26
07
2024
revised:
28
09
2024
accepted:
01
10
2024
medline:
16
10
2024
pubmed:
16
10
2024
entrez:
16
10
2024
Statut:
epublish
Résumé
Comprehensive next-generation sequencing (NGS) assays enable the identification of clinically relevant mutations, enhancing the capability for targeted therapeutic interventions. In addition, genomic alterations driving the oncogenic roadmap and leading to resistance mechanisms are reshaping precision oncology. We report the workflow and clinical and technical validation of the OncoIndx
Identifiants
pubmed: 39410034
pii: cancers16193415
doi: 10.3390/cancers16193415
pii:
doi:
Types de publication
Journal Article
Langues
eng